Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study

Breast cancer risk is increased with current Menopausal Hormone Therapy (MHT) use, with higher risks reported for ER+ (Estrogen Receptor positive), and ER+/PR+ (Estrogen and Progesterone Receptor positive) breast cancers than those of ER- and ER-/PR- status, respectively. There is limited evidence t...

Descripción completa

Detalles Bibliográficos
Autores principales: Salagame, Usha, Banks, Emily, O’Connell, Dianne L., Egger, Sam, Canfell, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221262/
https://www.ncbi.nlm.nih.gov/pubmed/30403669
http://dx.doi.org/10.1371/journal.pone.0205034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221262/
https://www.ncbi.nlm.nih.gov/pubmed/30403669
http://dx.doi.org/10.1371/journal.pone.0205034

Ejemplares similares